1. Home
  2. ARMP vs AREN Comparison

ARMP vs AREN Comparison

Compare ARMP & AREN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARMP
  • AREN
  • Stock Information
  • Founded
  • ARMP N/A
  • AREN 2016
  • Country
  • ARMP United States
  • AREN United States
  • Employees
  • ARMP N/A
  • AREN N/A
  • Industry
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • AREN Medical/Dental Instruments
  • Sector
  • ARMP Health Care
  • AREN Health Care
  • Exchange
  • ARMP Nasdaq
  • AREN Nasdaq
  • Market Cap
  • ARMP 80.0M
  • AREN 69.8M
  • IPO Year
  • ARMP N/A
  • AREN N/A
  • Fundamental
  • Price
  • ARMP $1.98
  • AREN $1.71
  • Analyst Decision
  • ARMP Strong Buy
  • AREN
  • Analyst Count
  • ARMP 1
  • AREN 0
  • Target Price
  • ARMP $7.00
  • AREN N/A
  • AVG Volume (30 Days)
  • ARMP 9.2K
  • AREN 216.0K
  • Earning Date
  • ARMP 11-13-2024
  • AREN 11-14-2024
  • Dividend Yield
  • ARMP N/A
  • AREN N/A
  • EPS Growth
  • ARMP N/A
  • AREN N/A
  • EPS
  • ARMP N/A
  • AREN N/A
  • Revenue
  • ARMP $5,467,000.00
  • AREN $234,396,000.00
  • Revenue This Year
  • ARMP N/A
  • AREN $12.73
  • Revenue Next Year
  • ARMP $83.33
  • AREN $71.95
  • P/E Ratio
  • ARMP N/A
  • AREN N/A
  • Revenue Growth
  • ARMP 34.92
  • AREN 45.45
  • 52 Week Low
  • ARMP $1.97
  • AREN $0.56
  • 52 Week High
  • ARMP $4.48
  • AREN $2.92
  • Technical
  • Relative Strength Index (RSI)
  • ARMP 38.26
  • AREN 63.69
  • Support Level
  • ARMP $1.97
  • AREN $1.55
  • Resistance Level
  • ARMP $2.30
  • AREN $1.79
  • Average True Range (ATR)
  • ARMP 0.11
  • AREN 0.16
  • MACD
  • ARMP -0.02
  • AREN -0.02
  • Stochastic Oscillator
  • ARMP 7.50
  • AREN 76.64

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about the things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.

Share on Social Networks: